Loading...

Telstra's investment in e-health tops AUD100 mn

Image

12-Feb-15 Telco giant Telstra's investments through its healthcare division have gone well beyond the $100 million mark. This includes acquisitions and joint ventures to provide technology solutions in telemedicine, aged and residential care, hospital, radiology and pathology and will help Telstra deliver a more integrated health system. Telstra Health has plans to buy more assets in the coming year. [image: B Busco_Getty Images]

Read More

Ageing China draws investors to its "hot" healthcare sector

Image

10-Feb-15 Encouraged by a relaxation of ownership rules in 2014 and a rapidly ageing population, PE firms and industry players are investing in China’s hospitals, pharmaceutical companies and device makers. The prospect of 223 million people aged 65+ by 2030 is enticing, despite risks such as rising valuations and a dearth of doctors. [image: Reuters]

Read More

Helping Myanmar Advance towards universal health coverage

Image

05-Feb-15 The Government of Myanmar signed a new agreement with the World Bank to bring improved maternal, newborn and child healthcare to millions of mothers and their young children. The Essential Health Services Access Project will provide US$100 million in funding for increased and improved coverage of critical health services across Myanmar’s 330 townships. [image: Joint Learning Network]

Read More

USD1.6 million funding for India’s tech startups

Image

02-Feb-15 A group of Indian healthcare operators, including Manipal Hospitals, Narayana Health and Pfizer, have got together with an investor to provide up to USD1.6 million in grants and investments to early-stage startups that seek to enhance access to affordable technology-driven healthcare products and services for the low-income population in India. [image: The Times of India]

Read More

Chugai Pharmaceutical to expand Singapore R&D unit

Image

31-Jan-15 Japan's Chugai Pharmaceutical will invest $476 million over the next seven years to expand its research institute in Singapore. The investment will make its centre at Biopolis one of the biggest pharmaceutical research and development operations in Singapore. It will also boost its "local employee base and antibody research and development pipeline", the company said. [image: Reuters]

Read More